CELZ

Creative Medical Technology Holdings, Inc. (CELZ) | Rumor.io

Creative Medical Technology Holdings

CELZ

Attention (50-day avg)0%

Attention rank (50-day avg)#1,495

Bullish sentiment (50-day avg)71%

Price to earnings ratio2.81

Market capitalization6.7M

Earnings per share-2.05

Dividend yield (TTM)—

Revenue (annual)6K

Net income (annual)-6M

Social

What share of all stock conversation is about CELZ?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% -0.01	0% +0

Sep 22

Creative Medical Technology Holdings, Inc. ($CELZ) is working on a Phase 3 data news announcement.
The stock has seen a 28-day streak below $1, with the clock starting over after a $1.005 close on the previous day.
The company has 4 employees, which is an interesting fact amidst its current market performance.

Generated by AI

Sentiment

Of the messages about CELZ that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	94.12% +28.08	73.24% +2.41	77.52% -12.72
Bearish	—	5.88% -28.08	26.76% -2.41	22.48% +12.72

Bullish· Sep 21

The company has announced patent news related to diabetes, which could lead to significant price increases.
A potential public relations announcement regarding olastrocel is expected, which could lead to a price surge.
The company's micro float has turned over multiple times, indicating a squeeze is likely, and the price could reach $2.00 to $3.00.

Bearish· Aug 10

The company, Creative Medical Technology Holdings, Inc. (CELZ), is seeking to quadruple its authorized common shares from 25M to 100M, which could lead to significant dilution of existing owners and potentially make a takeover or removal of management more difficult.
The CEO of CELZ received a $100,000 bonus for a "successful warrant exercise inducement transaction," which critics argue is a way to dilute longs and benefit management at the expense of shareholders.
Two hedge funds are allegedly planning to aggressively short the stock around the $1.30-$1.40 price zone, which could lead to a significant drop in the stock price.

Generated by AI

Topics

Of the messages about CELZ that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	86.21%	60.98%
Technical Analysis	—	0%	10.34%	24.99%
Macro	—	0%	0%	6.31%
Analysts	—	0%	0%	6.37%
Controversies	—	0%	3.45%	1.37%
Earnings	—	0%	0%	0%

Announcements· Aug 6

Creative Medical Technology Holdings, Inc. (CELZ) received a Notice of Allowance from the USPTO for a new U.S. patent covering exosome-based immunotherapy for Type 1 diabetes, deepening IP protection across its MyeloCelz, CELZ-101, and CELZ-201 diabetes platforms.
The company's new patent titled "SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS" is expected to strengthen its intellectual property position around its next-generation diabetes therapies.
Creative Medical Technology Holdings, Inc. has received a USPTO Notice of Allowance for a patent covering a novel diabetes-suppression method using stem cell–derived exosome technology, expanding its MyeloCelz IP estate.

Technical Analysis· Aug 7

$CELZ is holding above the halt gap, making the bullish setup safe, with a strong lower wick showing buyers stepping in on dips.
A clean breakout above $1.50 with volume could open the door for a second leg, with the next resistance level at $1.75.
$CELZ is breaking out of a falling wedge, and the author is grabbing some shares, while also noting the stock's 100% move and continuing trend.

Generated by AI

Community

Of the messages about CELZ, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	82.61%	22.9%	31.43%
Newcomers	0%	17.39%	77.1%	68.57%

Regulars· Aug 7

The price of CELZ has had a significant run, with one alert reaching 122% to $1.94.
The Creative Medical Technology Holdings, Inc. has received a Notice of Allowance for a new U.S. patent covering exosome-based immunotherapy for Type 1 Diabetes, deepening its IP protection.
Traders are actively participating in the discussion, with some buying and adding to their positions, while others are selling and expressing frustration with the market's performance.

Newcomers· Sep 21

The company, Creative Medical Technology Holdings, Inc., has been granted U.S. Patent No. 12,741,015 for its exosome-based approach to suppressing Type 1 diabetes.
Newcomers are optimistic about the stock's potential, with some predicting significant price increases, such as a 50-200% pop.
The patent news has led to a significant increase in the stock's price, with some users suggesting it could continue to rise, potentially reaching $1.40 or higher.

Generated by AI

News

12 Health Care Stocks Moving In Thursday's After-Market Session - Doximity (NYSE:DOCS), Creative Medical

Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 billion. The company's, Q1 earnings came out

1mo agoBenzinga

Creative Medical Technology Stock Surges After Key Patent Win - Creative Medical Tech (NASDAQ:CELZ)

Creative Medical Technology Holdings Inc. (NASDAQ: CELZ) shares are surging Thursday afternoon following an intellectual property milestone.

1mo agoBenzinga

12 Health Care Stocks Moving In Thursday's Intraday Session

1mo agoBenzinga

Also Discussed

Investors talking about CELZ also mention

#	Name	Attention
1	Sunshine Biopharma Inc.SBFM	0%0
2	BioRestorative Therapies, Inc.BRTX	0%0
3	Kidpik Corp.PIK	0%new
4	Biofrontera Inc.BFRI	0%0
5	Lixte Biotechnology Holdings Inc.LIXT	0%new
6	Maris-Tech Ltd.MTEK	0%-0.02
7	TNL Mediagene Ordinary SharesTNMG	0%new
8	TDH Holdings, Inc.PETZ	0%new
9	GMGI - Golden Matrix Group, Inc.	——
10	Innovate Corp.VATE	0%0

Creative Medical Technology Holdings, Inc.

Healthcare
Biotechnology

Creative Medical Technology Holdings, Inc. is a commercial-stage biotechnology company focused on regenerative medicine and novel biological therapeutics. The company develops products and programs across immunology, endocrinology, urogynecology, urology, neurology, and orthopedics, with an emphasis on stem cell-based and cell-derived approaches. Its portfolio includes therapies and platforms such as CaverStem, FemCelz, StemSpine, ImmCelz, and AlloStem, which are designed for a range of conditions including sexual health, spinal disorders, immune-related diseases, and other unmet medical needs. Creative Medical Technology Holdings, Inc. serves a specialized role in the healthcare market by advancing regenerative technologies from development into commercial use and clinical evaluation. Headquartered in Phoenix, Arizona, the company concentrates on translating biomedical research into targeted treatment options for patients and clinicians.

Website

Location

211 East Osborn Road

Phoenix, AZ, 85012

United States

Social

What share of all stock conversation is about CELZ?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% -0.01	0% +0

Sep 22

Creative Medical Technology Holdings, Inc. ($CELZ) is working on a Phase 3 data news announcement.
The stock has seen a 28-day streak below $1, with the clock starting over after a $1.005 close on the previous day.
The company has 4 employees, which is an interesting fact amidst its current market performance.

Generated by AI

Sentiment

Of the messages about CELZ that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	94.12% +28.08	73.24% +2.41	77.52% -12.72
Bearish	—	5.88% -28.08	26.76% -2.41	22.48% +12.72

Bullish· Sep 21

The company has announced patent news related to diabetes, which could lead to significant price increases.
A potential public relations announcement regarding olastrocel is expected, which could lead to a price surge.
The company's micro float has turned over multiple times, indicating a squeeze is likely, and the price could reach $2.00 to $3.00.

Bearish· Aug 10

The company, Creative Medical Technology Holdings, Inc. (CELZ), is seeking to quadruple its authorized common shares from 25M to 100M, which could lead to significant dilution of existing owners and potentially make a takeover or removal of management more difficult.
The CEO of CELZ received a $100,000 bonus for a "successful warrant exercise inducement transaction," which critics argue is a way to dilute longs and benefit management at the expense of shareholders.
Two hedge funds are allegedly planning to aggressively short the stock around the $1.30-$1.40 price zone, which could lead to a significant drop in the stock price.

Generated by AI

Topics

Of the messages about CELZ that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	86.21%	60.98%
Technical Analysis	—	0%	10.34%	24.99%
Macro	—	0%	0%	6.31%
Analysts	—	0%	0%	6.37%
Controversies	—	0%	3.45%	1.37%
Earnings	—	0%	0%	0%

Announcements· Aug 6

Creative Medical Technology Holdings, Inc. (CELZ) received a Notice of Allowance from the USPTO for a new U.S. patent covering exosome-based immunotherapy for Type 1 diabetes, deepening IP protection across its MyeloCelz, CELZ-101, and CELZ-201 diabetes platforms.
The company's new patent titled "SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS" is expected to strengthen its intellectual property position around its next-generation diabetes therapies.
Creative Medical Technology Holdings, Inc. has received a USPTO Notice of Allowance for a patent covering a novel diabetes-suppression method using stem cell–derived exosome technology, expanding its MyeloCelz IP estate.

Technical Analysis· Aug 7

$CELZ is holding above the halt gap, making the bullish setup safe, with a strong lower wick showing buyers stepping in on dips.
A clean breakout above $1.50 with volume could open the door for a second leg, with the next resistance level at $1.75.
$CELZ is breaking out of a falling wedge, and the author is grabbing some shares, while also noting the stock's 100% move and continuing trend.

Generated by AI

Community

Of the messages about CELZ, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	82.61%	22.9%	31.43%
Newcomers	0%	17.39%	77.1%	68.57%

Regulars· Aug 7

The price of CELZ has had a significant run, with one alert reaching 122% to $1.94.
The Creative Medical Technology Holdings, Inc. has received a Notice of Allowance for a new U.S. patent covering exosome-based immunotherapy for Type 1 Diabetes, deepening its IP protection.
Traders are actively participating in the discussion, with some buying and adding to their positions, while others are selling and expressing frustration with the market's performance.

Newcomers· Sep 21

The company, Creative Medical Technology Holdings, Inc., has been granted U.S. Patent No. 12,741,015 for its exosome-based approach to suppressing Type 1 diabetes.
Newcomers are optimistic about the stock's potential, with some predicting significant price increases, such as a 50-200% pop.
The patent news has led to a significant increase in the stock's price, with some users suggesting it could continue to rise, potentially reaching $1.40 or higher.

Generated by AI

Creative Medical Technology Holdings

Social

Sep 22

Bullish· Sep 21

Bearish· Aug 10

Announcements· Aug 6

Technical Analysis· Aug 7

Regulars· Aug 7

Newcomers· Sep 21

Creative Medical files patent application for Ultrasome platform

Creative Medical completes enrollment in chronic back pain trial

Top Microcaps CELZ, PRSO, HCWC, TOON: Shorted Stocks to Watch in August 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Doximity (NYSE:DOCS), Creative Medical

Creative Medical Technology Stock Surges After Key Patent Win - Creative Medical Tech (NASDAQ:CELZ)

12 Health Care Stocks Moving In Thursday's Intraday Session

Also Discussed

Creative Medical Technology Holdings, Inc.

Company Information

Location

Creative Medical files patent application for Ultrasome platform

Creative Medical completes enrollment in chronic back pain trial

Top Microcaps CELZ, PRSO, HCWC, TOON: Shorted Stocks to Watch in August 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Doximity (NYSE:DOCS), Creative Medical

Creative Medical Technology Stock Surges After Key Patent Win - Creative Medical Tech (NASDAQ:CELZ)

12 Health Care Stocks Moving In Thursday's Intraday Session

Also Discussed

Social

Sep 22

Bullish· Sep 21

Bearish· Aug 10

Announcements· Aug 6

Technical Analysis· Aug 7

Regulars· Aug 7

Newcomers· Sep 21